Vince Sliwoski

Vince is a business lawyer, problem solver and dealmaker. His clients run the gamut from individual investors and entrepreneurs to widely held domestic and international corporations. He is the managing attorney of our Portland office and he was recently again named a “Rising Star” by Super Lawyers Magazine, an honor bestowed on only 2.5% of eligible Oregon attorneys.

Canna Law Blog Card Default

The “Right to Try” Psilocybin and New Drug Therapies

I was talking to another lawyer about last week’s vote by Oregonians to legalize psilocybin therapy here in the state. We discussed how licensed facilities won’t be up and running for a few more years, and how, in the meantime, people will have to make do with general decriminalization under Measure 109 and maybe, in

oregon cannabis dispensary valuation

Oregon Cannabis Dispensary Sales: What We Are Seeing on Valuation

The Oregon secondary market for cannabis licenses and businesses remains lively. We have been helping industry buy and sell these businesses since 2016. This post is mostly about pricing for retail plays, which is still an evolving standard, but a standard nonetheless. First, some context. Over the past few years, there have been two significant

Oregon Psilocybin: Does Measure 109 Go Far Enough? Does it Go Too Far?

We are on record here at the law firm in support of Measure 109. We have friends and colleagues who have worked on the campaign and clients who have written checks, large and small. Legal psilocybin in Oregon? We like the sound of that. But do we unconditionally and unapologetically love the ballot measure? No,

Oregon Cannabis: Here Comes Streamlined Licensing (!!)

People have been complaining about Oregon Liquor Control Commission (OLCC) marijuana licensing bottlenecks for a long time. And rightfully so. New license applications are effectively suspended (and have been for over two years), while delays in approval requests for investment intake, ownership changes and business sales make these standard business activities extremely challenging in many

Federal Courts are Going Backward on Cannabis

A few weeks back, the Cannabis Law Institute invited me to discuss contract drafting for cannabis deals. A focal point for the panel was whether courts are willing to enforce cannabis contracts. The last time I had really looked at that issue was early 2019, when I wrote: Cannabis Dispute? Courts are Open. As the

The Oregon Fires and Cannabis

Wildfires are ravaging Oregon, Washington and California. They are truly terrible. Here in Oregon, a full 500,000 residents have been evacuated as I write this blog post on the evening of September 9. Portland smells like burning ash and the suburbs are in evacuation protocols. It’s awful even here. For the cannabis industry, things look

Oregon Cannabis Real Estate Sales

Buying and selling Oregon cannabis properties can be pretty interesting. We have helped negotiate and paper a ton of these sales going back to 2015 or so. The deal book includes everything from small commercial lots in the City of Portland (for retail dispensaries) to large sawmill properties in Southern Oregon (for hemp processing conversion).

Here Comes the First Approved MDMA (Ecstasy) Drug

Last week, the Multidisciplinary Association for Psychedelics Studies (MAPS) made a very big announcement: it had raised $30 million to complete its promising study of MDMA (ecstasy; molly) for treating post-traumatic stress disorder (PTSD). The Food and Drug Administration (FDA) already has granted MAPS “breakthrough therapy” approval based on earlier trials. With its recent cash

Kamala Harris Will Help With Cannabis Reform (and That’s Good Enough For Me)

Congratulations to Senator Kamala Harris, Joe Biden’s V.P. pick. Harris will become the first Black woman and the first person of Indian descent to be nominated for national office by a major party. It’s a huge accomplishment. It could also impact the race significantly in the coming weeks and months. What would a Vice President

How to Study Schedule I Controlled Substances

Q:  I want to study schedule I controlled substances. I want to study marijuana (cannabis), peyote, MDMA, psilocybin, LSD, ayahuasca/DMT and ibogaine, to start. A:  All of that is possible, but you should choose just one. Q:  OK, I want to study cannabis. A:  That’s actually one of the hardest. Please choose a better one.